Delivery Order SPE2DB20D2104-SPE2DB24FV34H
Award Date
7/23/24
Potential Completion Date
7/24/24
Potential Value
$1.9K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of Estrace 0.01% cream. The $1,464.42 firm fixed-price delivery order falls under a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that AmerisourceBergen holds with the DLA Troop Support Medical, which provides a comprehensive range of pharmaceutical products and medical supplies to support military healthcare...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,419.85 firm fixed-price delivery order is for the supply of Estrace 0.01% cream, a topical estrogen medication. This award is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen's parent company, Cencora, Inc., with the DLA Troop Support Medical, valued at up to $999,999,999.00 through...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., for the delivery of Estrace 0.01% Cream in 42.5 gram units. The $2,002.68 firm fixed-price delivery order is not designated as a set-aside contract. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the company to provide a comprehensive range of...
This federal contract award is for the delivery of Estrace 0.01% cream, a pharmaceutical product, to the Defense Logistics Agency (DLA) Troop Support Medical. The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for a firm fixed price of $2,486.70. The contract has an ultimate completion date of March 19, 2025 and does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a...
This federal contract award, valued at $1,620.41, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract involves the delivery of Estrace 0.01% Cream, a pharmaceutical product, and is a Firm Fixed Price Delivery Order without any set-aside designation. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and...
This federal contract award, with ID SPE2DB24D2101|SPE2DB25FKJSG, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,131.24 firm fixed-price delivery order is for the supply of Estrace 0.01% cream, 42.5 gm. This order is not associated with a set-aside program. Amerisourcebergen Drug Corp holds a substantial $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,739.91 firm fixed-price delivery order is for the supply of Estrace 0.01% cream, a topical estrogen medication, to support federal healthcare programs. The award is part of a broader $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, which serves as a...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract is for the delivery of Estrace 0.01% Cream, a pharmaceutical product, with a ceiling value of $1,331.41 and a completion date of March 4, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA, valued at $999,999,999 and running...
This federal contract award is for the delivery of Estrace 0.01% cream, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract, valued at $1,513.26, was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on June 2, 2023. The contract has a completion date of June 5, 2023 and is a Firm Fixed Price Delivery Order. This award is part of a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., holds...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp., a subsidiary of Amerisourcebergen Corporation, to provide Estrace 0.01% cream. The contract is a firm fixed price delivery order with a ceiling value of $1,736.50 and a period of performance through March 20, 2024. Amerisourcebergen Drug Corp. is the prime contractor for this award, which does not have a set-aside designation. The contract is a part of...